Clarification sought from Bharat Immunologicals & Biologicals Corporation Ltd
30-Sep-2026 | Source : BSEThe Exchange has sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd on September 30 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
Announcement under Regulation 30 (LODR)-Winding-up
17-Sep-2026 | Source : BSEPursuant to the Regulation 30 and other applicable Regulation(s) of SEBI LODR It is informed that the Government of India has approved the closure of Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) under Administrative control of Department of Biotechnology Ministry of Science & Technology Government of India. This information is being submitted with reference to the communication received on 17.09.2026 from Department of Biotechnology.
Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.
07-Aug-2024 | Source : BSEBHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available